Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cotroneo, M. S.
Right arrow Articles by Lamartiniere, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cotroneo, M. S.
Right arrow Articles by Lamartiniere, C. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 61, 68-75 (2001)
Copyright © 2001 by the Society of Toxicology

ENDOCRINE TOXICOLOGY

Pharmacologic, but Not Dietary, Genistein Supports Endometriosis in a Rat Model

Michelle S. Cotroneo and Coral A. Lamartiniere,1

Department of Pharmacology and Toxicology and the Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama 35294

Endometriosis is a disease in which uterine tissue proliferates in extrauterine sites. Using a surgical model to simulate endometriosis, we explored the potential for the phytoestrogen genistein, by injection and diet, to sustain endometriosis in rats. Uterine tissue was attached to intestinal mesentery of 8-week-old Sprague Dawley rats. After 3 weeks, the rats were ovariectomized and the implants measured. Following 3 weeks of daily injections or exposure to dietary genistein, animals were necropsied and implants located and measured. Injections of genistein (50 and 16.6 µg/g BW) or estrone (1 µg/rat) sustained the implants; injection of sesame oil (vehicle for estrone), dimethylsulfoxide (DMSO; vehicle for genistein), or genistein at 5.0 µg/g BW did not sustain implants. Dietary genistein (250 or 1000 mg genistein/kg AIN-76A diet) did not support the implants. In ovary-intact rats exposed to 250 mg genistein/kg AIN-76A diet, implant size was not altered, compared to control-fed animals. To assess estrogenic actions of genistein, we measured uterine estrogen receptor alpha (ER-{alpha}) and progesterone receptor (PR) isoforms A and B by Western blot analyses. Injections of estrone or genistein (50 or 16.6 µg/g BW) significantly reduced uterine ER-{alpha} compared to vehicle-treated animals. PR (B) was significantly increased by all injected doses of genistein or estrone and by the higher dietary dose (1000 mg genistein/kg AIN-76A). PR (A) was significantly increased by injected doses of genistein (16.6 and 5.0 µg/g BW). We conclude that pharmacologic injections, but not dietary physiological concentrations of genistein, support surgically induced endometriosis in rats. Our results suggest a critical role for ER modulation and genistein bioavailability in the maintenance of the implants.

Key Words: genistein; endometriosis; estrogen-; progesterone-receptors; uterus; rat.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
J Cumiskey, P Whyte, P Kelehan, and D Gibbons
A detailed morphologic and immunohistochemical comparison of pre- and postmenopausal endometriosis
J. Clin. Pathol., April 1, 2008; 61(4): 455 - 459.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
J. A. Ford Jr., S. G. Clark, E. M. Walters, M. B. Wheeler, and W. L. Hurley
Estrogenic effects of genistein on reproductive tissues of ovariectomized gilts
J Anim Sci, April 1, 2006; 84(4): 834 - 842.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
G. G. Hillman, Y. Wang, O. Kucuk, M. Che, D. R. Doerge, M. Yudelev, M. C. Joiner, B. Marples, J. D. Forman, and F. H. Sarkar
Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model
Mol. Cancer Ther., October 1, 2004; 3(10): 1271 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
W. A. Fritz, M. S. Cotroneo, J. Wang, I.-E. Eltoum, and C. A. Lamartiniere
Dietary Diethylstilbestrol but Not Genistein Adversely Affects Rat Testicular Development
J. Nutr., July 1, 2003; 133(7): 2287 - 2293.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. Wang, J. Gutkowska, M. Marcinkiewicz, G. Rachelska, and M. Jankowski
Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats
Cardiovasc Res, January 1, 2003; 57(1): 186 - 194.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. A. Lamartiniere, M. S. Cotroneo, W. A. Fritz, J. Wang, R. Mentor-Marcel, and A. Elgavish
Genistein Chemoprevention: Timing and Mechanisms of Action in Murine Mammary and Prostate
J. Nutr., March 1, 2002; 132(3): 552S - 558.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
C. A. Lamartiniere, J. Wang, M. Smith-Johnson, and I.-E. Eltoum
Daidzein: Bioavailability, Potential for Reproductive Toxicity, and Breast Cancer Chemoprevention in Female Rats
Toxicol. Sci., February 1, 2002; 65(2): 228 - 238.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.